On 11 September 2026, ASR Microelectronics (688220.SH) submitted a listing application to HKEX. The Company is a platform-based fabless semiconductor company which has built an integrated technology platform underpinned by multi-standard cellular baseband technology, AI computing technology and complex SoC design capabilities; according to Frost & Sullivan, it ranked first globally in the cellular connectivity chip market by shipment volume in 2025, with a market share of 37.8%.
On 11 September 2026, TIGERMED (03347.HK) announced that its actual controllers Ye Xiaoping and Cao Xiaochun received on the same day a warning letter and a Prior Notice of Administrative Penalty (Zhe Zheng Fa Zi [2026] No. 21) issued by the Zhejiang Regional Office of the CSRC, and that the two are proposed to be given a warning and fined RMB 1 million in aggregate for suspected violations in information disclosure relating to changes in shareholding.
On 11 September 2026, SINO-OCEAN GP (03377.HK) provided an inside information update on the failure of its wholly-owned subsidiary Beijing Sino-Ocean Holdings Group to repay matured debts and on its litigation: as at 31 August 2026, its matured and unpaid borrowings totalled RMB 16.694 billion (compared with RMB 18.160 billion at the end of 2025), increasing by RMB 294 million during August, with no new major litigation in August 2026 and one case remaining as a dishonest judgment debtor.
On 11 September 2026, the CSRC published the supplementary material requirements for overseas listing filing, requiring DST Sustainable Technology (Shenzhen) Co., Ltd. to supplement 4 items, including the pricing basis of historical capital increases and share transfers and verification of shareholding on trust, the subscription prices of shareholders newly added in the 12 months before the filing application, the impact of certain subsidiaries' failure to complete filing with the national automobile circulation information management system, and foreign investment access and title defects of "full circulation" shares.
On 11 September 2026, the CSRC published the supplementary material requirements for overseas listing filing, requiring Union Semiconductor (Hefei) Co., Ltd. to supplement 2 items, namely a further explanation of the necessity and rationality of its Hong Kong listing in light of the intended use of proceeds, and whether its principal business involves dual-use items and technologies prohibited or restricted from export, its outbound intellectual property licensing and transfers and its export control compliance system.
On 11 September 2026, the CSRC published the supplementary material requirements for overseas listing filing, requiring Guolian Green Technology (Wuxi) Co., Ltd. to supplement 6 items, including the pricing basis for historical capital increases and share transfers, whether pending litigation and external guarantees constitute a material obstacle, the progress of state-owned shareholding identification and other state-owned asset management procedures, and a plain-language introduction to its principal business.
On 11 September 2026, the CSRC published the supplementary material requirements for overseas listing filing, requiring Kunshan Wanyuantong Electronics Technology Co., Ltd. to supplement 4 items, including whether share pledges, borrowings and guarantees before and after the offering may lead to material title disputes or a change of controlling shareholder, the amounts and proportions of proceeds for domestic and overseas projects, all pending litigation and arbitration, and the regulatory procedures for establishing overseas subsidiaries.
On 11 September 2026, the CSRC published the supplementary material requirements for overseas listing filing, requiring Taihe Music Group to supplement 7 items, including whether its Hong Kong listing constitutes a spin-off by a Nasdaq-listed and Hong Kong Stock Exchange-listed company of its subsidiary for a separate listing, the reasons for adopting a trust structure for equity incentives, the administrative penalties repeatedly imposed on Chengdu Taihe, and the performance of regulatory procedures for its offshore structure and round-trip investment.
On 11 September 2026, the CSRC published the supplementary material requirements for overseas listing filing, requiring Tage iDriver Technology Co., Ltd. to supplement 13 items — the largest number in this round — covering the pricing of historical capital increases, the donation of shares by its actual controller, subscription prices of shareholders newly added in the past 12 months, shareholding on trust and equity incentives, use of proceeds, pending litigation and title defects of "full circulation" shares.
On 11 September 2026, the CSRC published the supplementary material requirements for overseas listing filing, requiring Hangzhou Lygo Technology Co., Ltd. to supplement 5 items, including the rationality of subscription prices of shareholders newly added in the 12 months before the filing application, shareholding on trust in its corporate history, the operations and revenue of its advertising design and agency businesses, and the compliance of its option incentive plan.
On 11 September 2026, the CSRC published the supplementary material requirements for overseas listing filing, requiring Zhejiang Kingdom New Material Group Co., Ltd. to supplement 10 items, including the relationships among shareholders holding less than 5%, the fairness of subscription prices of shareholders newly added in the past 12 months, equity incentives, the applicability of the negative list for foreign investment access, and the compliance of proceeds used for production base projects in Europe and Thailand.
On 11 September 2026, the CSRC published the supplementary material requirements for overseas listing filing, requiring Qunce Technology Co., Ltd. to supplement 6 items, including whether its Hong Kong listing constitutes a spin-off by a Taiwan Stock Exchange-listed company of its subsidiary for a separate listing, the necessity of establishing 21 employee shareholding platforms, share subscriptions by shareholders newly added in the past 12 months, and title defects of shares held by "full circulation" shareholders.
On 11 September 2026, the International Cooperation Department of the CSRC released a filing notice on overseas issuance and listing (Guohehan [2026] No. 1985, dated 18 August 2026), confirming the overseas issuance and listing filing of TINCI (002709.SZ), which intends to issue no more than 412,760,200 overseas-listed ordinary shares for listing on the Hong Kong Stock Exchange.
On September 11, 2026, the three major Hong Kong stock indices opened lower and moved in a choppy range, with the Hang Seng Index down 0.60%, the Hang Seng Tech Index down 0.23%, and the Hang Seng China Enterprises Index down 0.34%. Total turnover of the Hang Seng Index market for the full day was HK$228.4 billion. DAJIN rose 10.78%, as the shipbuilding sector sees a highly prosperous order intake and European offshore wind tenders are expected to form a catalyst; ZHIDA TECH, which surged yesterday, retraced 31.77%, with turnover of HK$1.147 billion.
The China Securities Regulatory Commission (CSRC) has recently issued a notice on the filing of the overseas offering and listing and the "Full Circulation" of unlisted domestic shares of AMICRO SEMICONDUCTOR CO., LTD. (Zhuhai Amicro Technology Co., Ltd.), confirming that the company intends to issue not more than 90,911,400 overseas-listed ordinary shares and to have them listed on The Stock Exchange of Hong Kong Limited, and that 43 shareholders intend to convert an aggregate of 360,133,644 unlisted domestic shares held by them into overseas-listed shares and to have them listed and traded on the Stock Exchange.
This week's Going Global Weekly contains 10 items, with pharmaceuticals and manufacturing forming the two main lines. On the pharmaceutical side, LEE'S PHARM obtained an exclusive licence from 1cBio, STAR SPORTS MED obtained EU CE MDR certification for its full product portfolio, and ASCLETIS-B and CLOVER BIO-B advanced their overseas clinical programmes in parallel; on the manufacturing side, FOUNTAIN SET acquired an 81% equity interest in a Vietnamese textile company for US$27.945 million, and ANJOY FOOD plans to contribute US$37.49625 million to establish a joint-venture production subsidiary in Indonesia. In terms of equity and financing, FOSUN PHARMA sold a 6% stake in India's Gland Pharma for approximately US$294 million, reducing its shareholding to approximately 45.76% while maintaining its controlling position.
